Investigators at University of Bari 'Aldo Moro' Detail Findings in Non-Small Cell Lung Cancer (Incidence and Predictors of Infections In Patients With Advanced Non-small Cell Lung Cancer Treated With Checkpoint Inhibitor Immunotherapies: a...).

Interestingly, autoimmune diseases were confirmed as risk factors in patients treated with ICIs as a first line, while previous infections were the only independent predictor of infections in patients treated with ICIs as a second line." Keywords: Bari; Italy; Europe; Autoimmune Diseases and Conditions; Autoimmunity; Cancer; Clinical Research; Clinical Trials and Studies; Drugs and Therapies; Health and Medicine; Immune System Diseases and Conditions; Immunology; Immunotherapy; Lung Cancer; Lung Diseases and Conditions; Lung Neoplasms; Non-Small Cell Lung Cancer; Oncology; Risk and Prevention; Therapy EN Bari Italy Europe Autoimmune Diseases and Conditions Autoimmunity Cancer Clinical Research Clinical Trials and Studies Drugs and Therapies Health and Medicine Immune System Diseases and Conditions Immunology Immunotherapy Lung Cancer Lung Diseases and Conditions Lung Neoplasms Non-Small Cell Lung Cancer Oncology Risk and Prevention Therapy 370 370 1 07/17/23 20230720 NES 230720 2023 JUL 18 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Investigators discuss new findings in Oncology - Non-Small Cell Lung Cancer. Investigators at University of Bari "Aldo Moro" Detail Findings in Non-Small Cell Lung Cancer (Incidence and Predictors of Infections In Patients With Advanced Non-small Cell Lung Cancer Treated With Checkpoint Inhibitor Immunotherapies: a...). [Extracted from the article]